User and problem
Ask: Who experiences the problem most often? What are they trying to accomplish? What triggers the situation? How do they solve it today? What does delay or failure cost them?
Observe behaviour where possible. A reported frustration is weaker evidence than a repeated workaround, budget line or missed opportunity.
Demand and differentiation
Ask: Who pays? What commitment have users made? Which alternatives compete for the same budget? Why would the product win? What advantage is difficult to copy?
Do not define the competitor list too narrowly. A spreadsheet, assistant or decision to do nothing may be the strongest alternative.
Feasibility and risk
Ask: Which data and integrations are required? What must be accurate? What are the security or legal consequences? Which assumption could make the product impossible? What is the smallest test?
For AI products, define examples of good and unacceptable output before choosing a model. Evaluation starts with the job, not the technology.
Economics and operation
Ask: What creates revenue or measurable value? What will each use cost? How will users be acquired? Who supports the product? What evidence will unlock the next investment?
Write the answers in one short discovery brief and identify what remains unknown. Wishmakers uses discovery to connect product ambition with an executable, operable system.
Build what comes next
Turn the idea into a working system.
Wishmakers designs, builds and operates AI-native products, software systems and digital ventures across Europe, Morocco and Brazil.
Product Engineering Contact Wishmakers
Frequently asked questions
How long should product discovery take?
It should be proportionate to the investment and risk. Focused discovery may take days or weeks, while complex regulated products need more evidence.
Does discovery end when development starts?
No. Discovery and delivery continue together as real product evidence changes the roadmap.
What is the output of discovery?
A clear problem, target user, tested assumptions, scope recommendation, risk map and next decision.